Loading…
AQST
Aquestive Therapeutics, Inc.
NASDAQ· Healthcare· Drug Manufacturers - Specialty & Generic· CUSIP 03843E104
$3.78-6.90%Price as of Oct 17, 12:03 UTC · updated once a day, after the close
At a glance
Aquestive Therapeutics, Inc. (AQST) is listed on NASDAQ and classified in Drug Manufacturers - Specialty & Generic, part of the Healthcare sector. It is headquartered in Warren, United States and has 147 employees. The company is worth $474.43M. Revenue was $44.55M in fiscal 2025, down 22.6% from the year before. It reported a net loss of $83.78M. The share price is 49.9% below its 52-week high of $7.55. 4 of the 38 superinvestors we track held it at the end of Q2 2026. The largest position belongs to Two Sigma (Two Sigma Investments), at $5.33M. In that quarter, 1 of them opened or added to the position. Over the last 30 days, company insiders sold $105.6K of its stock on the open market and bought none. All of those sales were scheduled in advance under 10b5-1 plans.
Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.
Key metrics
- Market cap
- $474.43M
- P/E
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.00%
- Payout
- —
- EPS
- -$0.66
- ROE
- —
- Profit margin
- -144.63%
- Revenue growth
- +38.10%
- Beta
- 1.49
- 52-week high
- $7.55
- 52-week low
- $2.93
History
Year by year, from the annual reports; dividends from the payments themselves.
Bars are year-end balances; lines are what happened during the year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▼ -35.9% over 5Y.
today you would have $735.41▼ -26.5%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 8 closed years, each at that year’s closing price and reported numbers.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Year-end price | $6.46 | $3.56 | $2.02 | $0.90 | $3.89 | $5.35 | $5.82 | $6.30 | |
| P/S | 3.4x | 17.7x | 6.1x | 2.9x | 1.1x | 3.2x | 4.2x | 3.7x | 2.3x |
| P/B | — | — | — | — | — | — | — |
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| RGNXREGENXBIO Inc. | $7.17 | — | 5.4x | 0.00% | -137.63% | $473.31M |
| NRCNRC Health | $21.38 | 89.1x | 72.2x | 2.99% | 42.03% | $472.92M |
| ENTXEntera Bio Ltd. | $2.68 | — | 18.2x | 0.00% | -138.92% | $465.88M |
| CERSCerus Corp | $2.31 |
About the company
- 147
- Warren, United States